Literature DB >> 20085558

Heart rate variability in type 2 spinocerebellar ataxia.

J Montes-Brown1, G Sánchez-Cruz, A M García, M E Báez, L Velázquez-Pérez.   

Abstract

OBJECTIVES: To explore cardiovascular autonomic regulation in Spinocerebellar ataxia type 2 (SCA2) patients, using heart rate variability (HRV) analysis and neurophysiologic autonomic reflex tests, and determine relations and causal related factors of dysautonomia in SCA2.
MATERIALS AND METHODS: Heart rate variability indices for 5 min series of RR intervals were analyzed in 97 SCA2 patients, assessed quantitatively for somatic and autonomic nervous system complaints applying the International Cooperative Ataxia Rating Scale and Scales for Outcomes in Parkinson's disease (SCOPA-AUT), respectively. Autonomic testing included: resting control, standing, Valsalva maneuver and deep breathing.
RESULTS: Mean RR, long- and short-term variability indices and spectral density power (LF, HF) indices were lower in the patients group, whereas LF/HF ratio and LF (nu) were higher. Highly differences between groups were observed for seven diagnostic autonomic test indices. Significant correlations were found between different clinical and demographic indices and between clinical indices and some HRV indices.
CONCLUSIONS: We confirm the presence of cardiovascular autonomic dysfunction in a large group of SCA2 patients.
Copyright © 2010 The Authors. Journal compilation © 2010 Blackwell Munksgaard.

Entities:  

Mesh:

Year:  2010        PMID: 20085558     DOI: 10.1111/j.1600-0404.2009.01320.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  7 in total

1.  Massive expansion of SCA2 with autonomic dysfunction, retinitis pigmentosa, and infantile spasms.

Authors:  A R Paciorkowski; Y Shafrir; J Hrivnak; M C Patterson; M B Tennison; H B Clark; C M Gomez
Journal:  Neurology       Date:  2011-08-31       Impact factor: 9.910

2.  Increased catabolic state in spinocerebellar ataxia type 1 patients.

Authors:  Anja Mähler; Jochen Steiniger; Matthias Endres; Friedemann Paul; Michael Boschmann; Sarah Doss
Journal:  Cerebellum       Date:  2014-08       Impact factor: 3.847

3.  Comprehensive study of early features in spinocerebellar ataxia 2: delineating the prodromal stage of the disease.

Authors:  Luis Velázquez-Pérez; Roberto Rodríguez-Labrada; Edilia M Cruz-Rivas; Juan Fernández-Ruiz; Israel Vaca-Palomares; Jandy Lilia-Campins; Bulmaro Cisneros; Arnoy Peña-Acosta; Yaimeé Vázquez-Mojena; Rosalinda Diaz; Jonathan J Magaña-Aguirre; Tania Cruz-Mariño; Annelié Estupiñán-Rodríguez; José M Laffita-Mesa; Rigoberto González-Piña; Nalia Canales-Ochoa; Yanetza González-Zaldivar
Journal:  Cerebellum       Date:  2014-10       Impact factor: 3.847

4.  Autonomic function testing in spinocerebellar ataxia type 2.

Authors:  Elisabetta Indelicato; Alessandra Fanciulli; Jean Pierre Ndayisaba; Wolfgang Nachbauer; Roberta Granata; Julia Wanschitz; Michaela Wagner; Elke R Gizewski; Werner Poewe; Gregor K Wenning; Sylvia Boesch
Journal:  Clin Auton Res       Date:  2018-02-12       Impact factor: 4.435

Review 5.  Spinocerebellar Ataxia Type 2: Clinicogenetic Aspects, Mechanistic Insights, and Management Approaches.

Authors:  Luis C Velázquez-Pérez; Roberto Rodríguez-Labrada; Juan Fernandez-Ruiz
Journal:  Front Neurol       Date:  2017-09-11       Impact factor: 4.003

6.  New spinocerebellar ataxia subtype caused by SAMD9L mutation triggering mitochondrial dysregulation (SCA49).

Authors:  Marc Corral-Juan; Pilar Casquero; Natalia Giraldo-Restrepo; Steve Laurie; Alicia Martinez-Piñeiro; Raidili Cristina Mateo-Montero; Lourdes Ispierto; Dolores Vilas; Eduardo Tolosa; Victor Volpini; Ramiro Alvarez-Ramo; Ivelisse Sánchez; Antoni Matilla-Dueñas
Journal:  Brain Commun       Date:  2022-02-10

7.  Body Mass Index Decline Is Related to Spinocerebellar Ataxia Disease Progression.

Authors:  Alhassane Diallo; Heike Jacobi; Tanja Schmitz-Hübsch; Arron Cook; Robyn Labrum; Alexandra Durr; Alexis Brice; Perrine Charles; Cecilia Marelli; Caterina Mariotti; Lorenzo Nanetti; Marta Panzeri; Maria Rakowicz; Anna Sobanska; Anna Sulek; Ludger Schöls; Holger Hengel; Bela Melegh; Alessandro Filla; Antonella Antenora; Jon Infante; José Berciano; Bart P van de Warrenburg; Dagmar Timmann; Sylvia Boesch; Massimo Pandolfo; Jörg B Schulz; Peter Bauer; Paola Giunti; Laszlo Baliko; Michael H Parkinson; Jun-Suk Kang; Thomas Klockgether; Sophie Tezenas du Montcel
Journal:  Mov Disord Clin Pract       Date:  2017-08-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.